BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Regenerative Patch Technologies Presents Clinical Data Demonstrating Long-Term Survival and Function of an Allogenic Bioengineered Cellular Implant in Patients with Advanced Dry Aged-Related Macular Degeneration.

  Clinical and Histological Results Signal Prolonged Effectiveness in the Treatment of Advanced Retinal Degenerative Diseases.

  February 4, 2022

   · 

  4 min read
• Drug Development

  Algernon Pharmaceuticals Announces Completion of Enrollment in its Phase 2 Study of Ifenprodil for IPF and Chronic Cough

  Algernon Pharmaceuticals Inc. is pleased to announce that it has completed enrollment in its Phase 2 NP-120 (“Ifenprodil”) idiopathic pulmonary fibrosis (“IPF’) and chronic cough study.

  February 4, 2022

   · 

  3 min read
• Business

  IRADIMED CORPORATION Announces Fourth Quarter 2021 Financial Results

  iRadimed Corporation today announced financial results for the three months and year ended December 31, 2021.

  February 4, 2022

   · 

  15 min read
• Business

  Viatris to Host Virtual Investor Event and Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022

  Viatris Inc. (NASDAQ: VTRS) will host its investor event the morning of Monday, February 28, 2022, beginning at 8:30 a.m. ET.

  February 4, 2022

   · 

  1 min read
• Biotech Beach

  Kintara Therapeutics to Present at BIO CEO & Investor Conference on February 15, 2022

  Kintara Therapeutics, Inc. today announced that its President and Chief Executive Officer, Robert E. Hoffman will present a corporate overview at the BIO CEO & Investor Conference, which is being held on February 14 – 17.

  February 4, 2022

   · 

  3 min read
• Business

  Bruker Expands Nanoflow Consumables Portfolio for 4D-Proteomics™

  Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of PepSep.

  February 4, 2022

   · 

  4 min read
• Business

  Exicure, Inc. Announces Leadership Transition and Changes to the Board of Directors

  Exicure, Inc. Announces Leadership Transition and Changes to the Board of Directors.

  February 4, 2022

   · 

  7 min read
• Biotech Bay

  Cytokinetics Announces FDA Acceptance of New Drug Application for Omecamtiv Mecarbil for the Treatment of Heart Failure With Reduced Ejection Fraction

  Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & Drug Administration (FDA) has accepted and filed the company’s New Drug Application (NDA) for omecamtiv mecarbil.

  February 4, 2022

   · 

  6 min read
• Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to all P2X3 Assets

  Evotec SE announces today that the Company has been informed by Bayer about a decision to discontinue the development of the investigational P2X3 receptor antagonist eliapixant (BAY1817080), which stems from a former Evotec/Bayer multi-target research alliance.

  February 4, 2022

   · 

  1 min read
• Business

  Twist Bioscience Reports First Quarter 2022 Financial Results

  Twist Bioscience Corporation today reported financial results and business highlights for the first quarter of fiscal 2022 ended December 31, 2021.

  February 4, 2022

   · 

  11 min read